Carl Edin

Carl Edin

Auto-generated profile, based on publicly available information

Carl Edin

Department of Health Medicine and Caring Sciences Linkoping University Linkoping Sweden

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2025 in Journal of Internal Medicine
Verified
Journal Article
Open access
WBWile Balkhed
Wile Balkhed
MBMartin Bergram
Martin Bergram
FIFredrik Iredahl
Fredrik Iredahl
MHMarkus Holmberg
Markus Holmberg
CECarl Edin
Carl Edin
MEMattias Ekstedt
Mattias Ekstedt
Background and aims: The prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) has increased during the epidemic of obesity. Type 2 diabetes mellitus (T2DM) is associated with progressive MASLD. Therefore, many guidelines recommend screening for MASLD in patients with T2DM. Most studies in patients with MASLD have been conducted in specialist care. We investigated the prevalence and severity of MASLD in patients with T2DM from primary care. Methods: Patients with T2DM were prospectively included from primary care facilities to undergo transient elastography with controlled attenuation parameter and whole‐body magnetic resonance imaging (MRI) to assess liver fat, cardiac function, muscle composition, and distribution of body fat. Results: Among 308 participants, 59% had MASLD, 7% had suspected advanced fibrosis (transient elastography ≥ 10 kPa), and 1.9% had cirrhosis. The mean age was 63.9 ± 8.1 years; 37% were female, with no differences between the MASLD and the non‐MASLD groups. Participants with MASLD had greater body mass index (31.1 ± 4.4 vs. 27.4 ± 4.1 kg/m 2 , p  < 0.001) and a higher prevalence of obesity (60% vs. 21%, p < 0.001). Obesity increased the risk of fibrotic MASLD eightfold, as confirmed by multivariable analysis. Participants with MASLD also had increased visceral and abdominal subcutaneous adipose tissue and muscle fat infiltration. On cardiac MRI, participants with MASLD had a lower left ventricular (LV) stroke volume index, a lower LV end‐diastolic volume index, and an increased LV concentricity. Conclusions: In this cohort of primary care patients with T2DM, 59% had MASLD, and 7% had suspected advanced fibrosis. Obesity was a strong predictor of fibrotic MASLD. MASLD was associated with alterations to the left ventricle and increased deposition of ectopic fat.